- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Weak Economy Hurts HC Starck’s 2013 Profit
HC Starck Inc. released its results for the 2013 fiscal year, commenting that its sales came to a total of 703.9 million euros, below the year-ago figure of 862.9 million euros.
HC Starck Inc. released its results for the 2013 fiscal year, commenting that its sales came to a total of 703.9 million euros, below the year-ago figure of 862.9 million euros.
Explaining the decline, CEO Andreas Meier cited “the weak development of the overall economy and sluggish growth in our key markets and target industries especially in the tantalum segment.”
Elaborating further, the press release states:
Especially in the tantalum and niobium powder segment, H.C. Starck registered very restrained demand from the electronics industry due to structural changes in consumer electronics and de-stocking activities at key customers. Sales of tantalum components such as sputtering targets also declined due to customer initiatives to reduce existing stock and the weakening of the project business from the chemicals industry.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.